Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Alteration of Dopamine Receptors Subtypes in the Brain of Opioid Abusers: A Postmortem Study in Iran Publisher Pubmed



Sadatshirazi MS1, 2 ; Zarrindast MR2, 3, 4 ; Daneshparvar H5 ; Ziaie A6 ; Fekri M2 ; Abbasnezhad E7 ; Ashabi G8 ; Khalifeh S9 ; Vousooghi N1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neuroscience, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Pharmacology Department, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Endocrinology and Metabolism Research Institute, Tehran University of Medical Science, Tehran, Iran
  5. 5. Legal Medicine Research Center, Legal Medicine Organization, Tehran, Iran
  6. 6. Legal Medicine Center, Tehran, Iran
  7. 7. School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  8. 8. Physiology Department, Tehran University of Medical Sciences, Tehran, Iran
  9. 9. Cognitive and Neuroscience Research Center (CNRC), Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran

Source: Neuroscience Letters Published:2018


Abstract

Dopamine is the most important neurotransmitter which is involved in reward and addiction. Repeated drug exposure can induce some adaptive changes in the molecular and cellular function of the mesolimbic dopaminergic system. Since the essential role of dopamine in the pathophysiology of drug addiction is proven, the changes in dopamine receptors level in the brain of opioid abusers and matched control subjects were investigated. Fifty-six opioid abusers and thirteen control subjects were obtained from Legal Medicine Center. The cause of death and the postmortem interval were determined by forensic pathologists. mRNA expression and protein level of dopamine receptors in the ventral tegmental area (VTA), nucleus accumbens (NAC) and amygdala were assessed. The mRNA and protein level of DRD1 increased in the VTA, NAC and amygdala of opioid abusers. DRD2 protein level increased in the VTA, NAC and amygdala of opioid abusers when compared with the control. DRD3 level decreased in all the brain regions except in the amygdala of opioid abusers in comparison with the control group. DRD4 mRNA level increased only in the amygdala of opioid abusers. There were no significant changes in the protein and mRNA levels of DRD4 in the VTA and NAC. In mRNA and protein level of DRD5, it followed the same pattern like DRD1. The current data suggest that adaptive changes in mRNA and protein level of dopamine receptors occurred in the brain of opioid abusers and the variations depended on the brain region. © 2018 Elsevier B.V.
Other Related Docs
9. The Modulatory Role of Dopamine in Anxiety-Like Behavior, Archives of Iranian Medicine (2015)